New 3-[4-(aryl)piperazin-1-yl]-1(benzo[b]thiophen-3-yl) propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

被引:50
|
作者
Martínez, J
Pérez, S
Oficialdegui, AM
Heras, B
Orús, L
Villanueva, H
Palop, JA
Roca, J
Mourelle, M
Bosch, A
Del Castillo, JC
Lasheras, B
Tordera, R
del Río, J
Monge, A
机构
[1] Univ Navarra, Dept Med Chem, E-31080 Pamplona, Spain
[2] Univ Navarra, CIFA, E-31080 Pamplona, Spain
[3] Univ Navarra, Dept Pharmacol, E-31080 Pamplona, Spain
[4] Vita Invest SA, Barcelona 08970, Spain
关键词
arylpiperazines; antidepressant; 5-HT1A antagonist; serotonin reuptake inhibitor;
D O I
10.1016/S0223-5234(00)01198-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives were synthesized in an attempt to find a new class of antidepressant drugs with dual activity at 5-HT1A serotonin receptors and serotonin transporter. Title compounds were evaluated for in vitro activity on 5-HT1A receptor and 5-HT transporter. They show high nanomolar affinity for both activities, and in particular, compounds 1-(5-chlorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-1-ol (7) and 1-(5-fluorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl) piperain-1-yl]propan-1-ol (8) show values (nM) of K-i = 30 and 2.3 for 5-HT1A receptors and K-i = 30 and 12 for serotonin transporters, respectively. In GTP gammaS binding assays, compound 8 revealed antagonist properties to 5-HT1A receptors. Such a pharmacological profile could lead to potent antidepressant agents with new dual mechanism of action. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 50 条
  • [31] Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor
    Zhou, Dahui
    Hatzenbuhler, Nicole T.
    Gross, Jonathan L.
    Harrison, Boyd L.
    Evrard, Deborah A.
    Chlenov, Michael
    Golembieski, Jeannette
    Hornby, Geoffrey
    Schechter, Lee E.
    Smith, Deborah L.
    Andree, Terrance H.
    Stack, Gary P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) : 3117 - 3121
  • [32] MEDI 58-Novel 2-(piperazin-1-yl)quinoline analogs as combined selective serotonin reuptake inhibitors and 5-HT1A receptor antagonists
    Zhou, Dahui
    Stack, Gary P.
    Lo, Jennifer
    Failli, Amedeo A.
    Evrard, Deborah A.
    Harrison, Boyd L.
    Hatzenbuhler, Nicole T.
    Croce, Susan
    Yi, Soo
    Tran, Megan
    Boikess, Steve
    Golembieski, Jeannette
    Hornby, Geoffrey
    Lai, Margaret
    Lin, Qian
    Schechter, Lee E.
    Schilling, Adam D.
    Smith, Deborah L.
    Huselton, Christine
    Beyer, Chad
    Andree, Terrance H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [33] Design, Synthesis and 5-HT1A Binding Affinity of N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)tricyclo[3.3.1.13,7]decan-1-amine and N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[3.3.1.13,7]decan-1-amine
    Zoidis, Grigoris
    Isabel Loza, Maria
    Catto, Marco
    MOLBANK, 2022, 2022 (01)
  • [34] 3-[4-(2-Phenylethyl)piperazin-1-yl]-7H-benzo[de]anthracen-7-one
    Fridmans, Romans
    Puckins, Aleksandrs
    Osipovs, Sergejs
    Belyakov, Sergey
    Kirilova, Elena
    MOLBANK, 2023, 2023 (01)
  • [35] (E)-3-(1,3-Benzodioxol-5-yl)-1-{4-[bis(4-methoxyphenyl) methyl] piperazin-1-yl}prop- 2-en-1-one
    Zhong, Yan
    Wu, Bin
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O636 - U1632
  • [36] 3-(Adamantan-1-yl)-4-methyl-1-({4-[3( trifluoromethyl) phenyl] piperazin-1-yl}methyl)- 4,5-dihydro-1H-1,2,4-triazole-5thione
    El-Emam, Ali A.
    Al-Tamimi, Abdul-Malek S.
    Alrashood, Khalid A.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O695 - +
  • [37] Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles
    van Niel, MB
    Collins, I
    Beer, MS
    Broughton, HB
    Cheng, SKF
    Goodacre, SC
    Heald, A
    Locker, KL
    MacLeod, AM
    Morrison, D
    Moyes, CR
    O'Connor, D
    Pike, A
    Rowley, M
    Russell, MGN
    Moyes, CR
    O'Connor, D
    Pike, A
    Rowley, M
    Russell, MGN
    Sohal, B
    Stanton, JA
    Thomas, S
    Verrier, H
    Watt, AP
    Castro, JL
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) : 2087 - 2104
  • [38] 1-(4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-5-yl)-2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethanone
    Zhi, Shuang
    Zheng, Guo
    Liu, Ying
    Liu, Deng-Ke
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1293 - +
  • [39] Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl) pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT1A receptor and SERT
    Wrobel, Martyna Z.
    Chodkowski, Andrzej
    Dawidowski, Maciej
    Siwek, Agata
    Stachowicz, Katarzyna
    Szewczyk, Bernadeta
    Nowak, Gabriel
    Satala, Grzegorz
    Bojarski, Andrzej J.
    Turlo, Jadwiga
    BIOORGANIC CHEMISTRY, 2023, 141
  • [40] Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors:: 3-(1H-indol-1-yl)-3-arylpropan-1-amines
    Mahaney, Paige E.
    Vu, An T.
    McComas, Casey C.
    Zhang, Puwen
    Nogle, Lisa M.
    Watts, William L.
    Sarkahian, Ani
    Leventhal, Liza
    Sullivan, Nicole R.
    Uveges, Albert J.
    Trybulski, Eugene J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) : 8455 - 8466